Life Science Company News

Results 161 - 180 out of 500 displayed.
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Abstract Published in ASCO 2024 Annual Meeting Book Showcases Validity of Belong.Life's Conversational AI Cancer Mentor 'Dave'

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at ASCO 2024

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Blueprint Medicines to Present the First Promising and Most Advanced Clinical Data for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer at the 2024 ASCO Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal Melanoma

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Landmark Study from Mercy BioAnalytics and University College London Demonstrates Significant Improvement Over CA125 and Ultrasound for Ovarian Cancer Screening

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

EDETEK Launches Continuous Study Monitoring Module for CONFORM™ Informatics

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Sapience Therapeutics to Showcase Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Photocure ASA - Annual general meeting held

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Families Across Canada are Walking to Defeat Duchenne Muscular Dystrophy on May 26

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Approximately half of patients living with inflammatory bowel disease (IBD) have suboptimally controlled disease, according to data from new Canadian study

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Read more ››
By: PR Newswire Association LLC. - 23 May 2024

Disclosure of voting rights at AGM in Vistin Pharma ASA

Read more ››
By: GlobeNewswire - 23 May 2024

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

Read more ››
By: GlobeNewswire - 23 May 2024

ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS

Read more ››
By: GlobeNewswire - 23 May 2024

Script Runner launches Canada’s first AI-powered drone delivery service, revolutionizing healthcare access for remote communities

Read more ››
By: GlobeNewswire - 23 May 2024

Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more

Read more ››
By: GlobeNewswire - 23 May 2024

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

Read more ››
By: GlobeNewswire - 23 May 2024
Results 161 - 180 out of 500 displayed.
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate